Skip to main content
NCBI home page
Archives of Disease in Childhood logoLink to Archives of Disease in Childhood
. 1959 Dec;34(178):501–504. doi: 10.1136/adc.34.178.501

The Effect of Calomel on Plasma Epinephrine in the Rat and the Relationship to Mechanisms in Pink Disease*

Donald B Cheek, Fannie Wu
PMCID: PMC2012428  PMID: 13809551

Full text

PDF
501

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. AXELROD J., TOMCHICK R. Enzymatic O-methylation of epinephrine and other catechols. J Biol Chem. 1958 Sep;233(3):702–705. [PubMed] [Google Scholar]
  2. BARBER J. K., BARTTER F. C., DELEA C., DUNCAN L. E., Jr, LIDDLE G. W. The regulation of aldosterone secretion in man: the role of fluid volume. J Clin Invest. 1956 Nov;35(11):1306–1315. doi: 10.1172/JCI103386. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. BOWER B. D. Pink disease: the autonomic disorder and its treatment with ganglion-blocking agents. Q J Med. 1954 Apr;23(90):215–230. [PubMed] [Google Scholar]
  4. CHEEK D. B. Pink disease; infantile acrodynia; a physiological approach; an evaluation of adrenal function and the importance of water and electrolyte metabolism. J Pediatr. 1953 Feb;42(2):239–260. doi: 10.1016/s0022-3476(53)80220-9. [DOI] [PubMed] [Google Scholar]
  5. FARQUHAR J. W., CRAWFORD T. B., LAW W. Urinary sympathin excretion of normal infants and of infants with pink disease. Br Med J. 1956 Aug 4;2(4987):276–281. doi: 10.1136/bmj.2.4987.276. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. GILLESPIE A. E. Acrodynia treated with 2-benzyl-imidazoline hydrochloride. Can Med Assoc J. 1952 Nov;67(5):418–421. [PMC free article] [PubMed] [Google Scholar]
  8. RAMEY E. R., GOLDSTEIN M. S. The adrenal cortex and the sympathetic nervous system. Physiol Rev. 1957 Apr;37(2):155–195. doi: 10.1152/physrev.1957.37.2.155. [DOI] [PubMed] [Google Scholar]
  9. SCHWARTZ H. C., CARTWRIGHT G. E., SMITH E. L., WINTROBE M. M. Studies on the biosynthesis of heme from iron and protoporphyrin. Blood. 1959 Apr;14(4):486–497. [PubMed] [Google Scholar]
  10. VULLIAMY D. G. The vasomotor disturbance in pink disease. Lancet. 1952 Dec 27;2(6748):1248–1251. doi: 10.1016/s0140-6736(52)90848-9. [DOI] [PubMed] [Google Scholar]
  11. WEIL-MALHERBE H., BONE A. D. The chemical estimation of adrenaline-like substances in blood. Biochem J. 1952 Jun;51(3):311–318. doi: 10.1042/bj0510311. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. WESTON R. E., ESCHER D. J. W., GROSSMAN J., LEITER L. Mechanisms contributing to unresponsiveness to mecurial diuretics in congestive failure. J Clin Invest. 1952 Oct;31(10):901–910. doi: 10.1172/JCI102678. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. WILLIAMS H., MACDONALD W. B., CALLOW V. Pink disease: its relation to adrenal function and the value of salt and desoxycorticosterone in treatment. Med J Aust. 1951 Mar 10;1(10):363–365. doi: 10.5694/j.1326-5377.1951.tb55772.x. [DOI] [PubMed] [Google Scholar]

Articles from Archives of Disease in Childhood are provided here courtesy of BMJ Publishing Group

RESOURCES